Primary Record
harringtonine
- In stock
- 6,976 g
- Purity
- 98.1 %
- CAS
- 26833-85-2
Compound Identifiers & Properties
- CAS
- 26833-85-2
- PubChem CID
- 276389
- SMILES
- CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
- Canonical SMILES
- COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4
Names & Synonyms
- harringtonine
- Harringtonin
- 2'R-Harringtonine
- Cephalotaxine
- 26833-85-2
- harringtonine(8ci)
- harringtonine, (R)-
- Alkaloid C from cephalotaxus
- AC1Q5YWP
- ZJ-H
- RefChem:783399
- CHEBI:5626
- NSC-124147
- AC1L5JQ6
- Cephalotaxine, [3(R)]-
- Epitope ID:2138076
- C28H37NO9
- SCHEMBL138806
- HARRINGTONINE [WHO-DD]
- NSC124147
- CHEMBL433257
- DTXSID501016801
- orb1299065
- UNII-088662H40F
- NSC 124147
- HAVJATCHLFRDHY-KSZYUSJVSA-N
- DTXCID701474996
- HY-N0862
- AR-1J1467
- BDBM50480315
- C28-H37-N-O9
- CID276389
- MFCD28978177
- NP0070
- s9063
- ZINC29412110
- 088662H40F
- AKOS030526125
- ACN-035590
- CCG-269921
- CS-3909
- EBC-615332
- FH15975
- HARRINGTONINE (REFERENCE GRADE)
- AS-56357
- J48.396F
- NCI60_000568
- SC-76215
- FT-0626865
- FT-0777281
- TRANS-2-BUTENE-1,4-DICARBOXYLICACID
- C10597
- A877127
- Q27106830
- Z2967326050
- Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester)
- 62624-24-2
- Cephalotaxine, 4-methyl 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester)
- (4bS,8aS,9S)-4,9-dihydroxy-2-isopropyl-4b,8,8-trimethyl-6,7,8a,9-tetrahydro-5H-phenanthren-3-one
- (R)-1-((11bS,12S,14aR)-13-Methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl 2-hydroxy-2-(3-hydroxy-3-methylbutyl)succinate
- 1-((1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-1-yl) 4-methyl (R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)succinate
- 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate
- 3-[4-Methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate]cephalotaxine
- 3-4-Methyl-(2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioatecephalotaxine
- Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate]
- O~3~-[(2R)-2,5-Dihydroxy-2-(2-methoxy-2-oxoethyl)-5-methylhexanoyl]cephalotaxine
- (2R)-2-Hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioic acid 1-[(3S)-3-deoxycephalotaxine-3-yl]4-methyl ester
- (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0^{2,6}.0^{6,10}.0^{15,19}]icosa-1(13),4,14,19-tetraen-3-yl 1-methyl (3R)-3-hydroxy-3-(3-hydroxy-3-methylbutyl)butanedioate
- (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3R)-3-hydroxy-3-(3-hydroxy-3-methylbutyl)butanedioate
- 1-((1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-1-yl) 4-methyl (R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)succina
- 1-O-((2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo(11.7.0.02,6.06,10.015,19)icosa-1(20),4,13,15(19)-tetraen-3-yl) 4-O-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate
- 2-Hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioic acid 1-[(3R)-3-deoxycephalotaxin-3-yl]4-methyl ester
- 25302-09-4
- 6276-37-5
- Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester) (9CI)
- Cephalotaxine, 4-methyl 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester), [3(R)]-
- Cephalotaxine, 4-methyl-, 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester), (3(R))-
- Cephalotaxine, 4-methyl-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester), (3(R))-
- HT
- O1-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] O4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methyl-butyl)butanedioate
- TE